DBV.PA - Dbv Technologies SA
Guggenheim Securities LLCEstimate Increase
DBVT- Highlights From FDA Expert Panel On Food Allergies & Breakfast Discussion at AAAAI 2026; Regulators & Allergists View VIASKIN As Next-Gen Immunotherapy For FA
公司
DBV.PA
日期
2026-03-02
分析师
Mr. Yatin Suneja
页数
7 页
需要登录
请登录后购买研报或生成音频内容。